메뉴 건너뛰기




Volumn 35, Issue 4, 2014, Pages 2905-2921

The association between the ERCC1/2 polymorphisms and the clinical outcomes of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC): A systematic review and meta-analysis

Author keywords

Chemotherapy; ERCC1; ERCC2; Meta analysis; NSCLC; Pharmacogenetics; Platinum; SNP

Indexed keywords

EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; PLATINUM DERIVATIVE; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 84898801591     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1493-5     Document Type: Review
Times cited : (36)

References (76)
  • 1
    • 77955635233 scopus 로고    scopus 로고
    • Cancer statistics, 2010
    • 10.3322/caac.20073 20610543
    • Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277-300. doi: 10.3322/caac.20073.
    • (2010) CA Cancer J Clin , vol.60 , Issue.5 , pp. 277-300
    • Jemal, A.1    Siegel, R.2    Xu, J.3    Ward, E.4
  • 2
    • 52649131951 scopus 로고    scopus 로고
    • Lung cancer
    • 10.1056/NEJMra0802714 1:CAS:528:DC%2BD1cXhtFKjt7bM 18815398
    • Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med. 2008;359(13):1367-80. doi: 10.1056/NEJMra0802714.
    • (2008) N Engl J Med , vol.359 , Issue.13 , pp. 1367-1380
    • Herbst, R.S.1    Heymach, J.V.2    Lippman, S.M.3
  • 3
    • 33745870113 scopus 로고    scopus 로고
    • Surgery for non-small cell lung cancer: Systematic review and meta-analysis of randomised controlled trials
    • 10.1136/thx.2005.051995 1:STN:280:DC%2BD28vivVeiug%3D%3D 2104670 16449262
    • Wright G, Manser RL, Byrnes G, Hart D, Campbell DA. Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials. Thorax. 2006;61(7):597-603. doi: 10.1136/thx.2005.051995.
    • (2006) Thorax , vol.61 , Issue.7 , pp. 597-603
    • Wright, G.1    Manser, R.L.2    Byrnes, G.3    Hart, D.4    Campbell, D.A.5
  • 5
    • 0036732039 scopus 로고    scopus 로고
    • Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells
    • 1:CAS:528:DC%2BD38XmslylurY%3D 12208738
    • Furuta T, Ueda T, Aune G, Sarasin A, Kraemer KH, Pommier Y. Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells. Cancer Res. 2002;62(17):4899-902.
    • (2002) Cancer Res , vol.62 , Issue.17 , pp. 4899-4902
    • Furuta, T.1    Ueda, T.2    Aune, G.3    Sarasin, A.4    Kraemer, K.H.5    Pommier, Y.6
  • 7
    • 78049423379 scopus 로고    scopus 로고
    • Association between polymorphisms of ERCC1 and XPD and clinical response to platinum-based chemotherapy in advanced non-small cell lung cancer
    • 10.1097/COC.0b013e3181b9cedc 1:CAS:528:DC%2BC3cXht1OisrbO 20351547
    • Li F, Sun X, Sun N, Qin S, Cheng H, Feng J, et al. Association between polymorphisms of ERCC1 and XPD and clinical response to platinum-based chemotherapy in advanced non-small cell lung cancer. Am J Clin Oncol. 2010;33(5):489-94. doi: 10.1097/COC.0b013e3181b9cedc.
    • (2010) Am J Clin Oncol , vol.33 , Issue.5 , pp. 489-494
    • Li, F.1    Sun, X.2    Sun, N.3    Qin, S.4    Cheng, H.5    Feng, J.6
  • 8
    • 74049160018 scopus 로고    scopus 로고
    • Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma
    • 10.1186/1471-2407-9-439 2803496 20003463
    • Yin Z, Zhou B, He Q, Li M, Guan P, Li X, et al. Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma. BMC cancer. 2009;9:439. doi: 10.1186/1471-2407-9-439.
    • (2009) BMC Cancer. , vol.9 , pp. 439
    • Yin, Z.1    Zhou, B.2    He, Q.3    Li, M.4    Guan, P.5    Li, X.6
  • 9
    • 0019365237 scopus 로고
    • Reporting results of cancer treatment
    • 1:STN:280:DyaL3M7htFOltw%3D%3D 7459811
    • Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47(1):207-14.
    • (1981) Cancer , vol.47 , Issue.1 , pp. 207-214
    • Miller, A.B.1    Hoogstraten, B.2    Staquet, M.3    Winkler, A.4
  • 10
    • 0034594628 scopus 로고    scopus 로고
    • New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
    • 1:STN:280:DC%2BD3c7it1Gitg%3D%3D 10655437
    • Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92(3):205-16.
    • (2000) J Natl Cancer Inst , vol.92 , Issue.3 , pp. 205-216
    • Therasse, P.1    Arbuck, S.G.2    Eisenhauer, E.A.3    Wanders, J.4    Kaplan, R.S.5    Rubinstein, L.6
  • 11
    • 34547450763 scopus 로고    scopus 로고
    • Practical methods for incorporating summary time-to-event data into meta-analysis
    • 10.1186/1745-6215-8-16 1920534 17555582
    • Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. doi: 10.1186/1745-6215-8-16.
    • (2007) Trials , vol.8 , pp. 16
    • Tierney, J.F.1    Stewart, L.A.2    Ghersi, D.3    Burdett, S.4    Sydes, M.R.5
  • 12
    • 0041876133 scopus 로고    scopus 로고
    • Measuring inconsistency in meta-analyses
    • 10.1136/bmj.327.7414.557
    • Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clin Res). 2003;327(7414):557-60. doi: 10.1136/bmj.327.7414. 557.
    • (2003) BMJ (Clin Res) , vol.327 , Issue.7414 , pp. 557-560
    • Higgins, J.P.1    Thompson, S.G.2    Deeks, J.J.3    Altman, D.G.4
  • 13
    • 84959801619 scopus 로고
    • Statistical aspects of the analysis of data from retrospective studies of disease
    • 1:STN:280:DyaG1M%2FosVOhtQ%3D%3D 13655060
    • Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719-48.
    • (1959) J Natl Cancer Inst , vol.22 , Issue.4 , pp. 719-748
    • Mantel, N.1    Haenszel, W.2
  • 14
    • 0022992740 scopus 로고
    • Meta-analysis in clinical trials
    • 1:STN:280:DyaL2s7gsVamtA%3D%3D 3802833
    • DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88.
    • (1986) Control Clin Trials , vol.7 , Issue.3 , pp. 177-188
    • Dersimonian, R.1    Laird, N.2
  • 15
    • 0028659004 scopus 로고
    • Operating characteristics of a rank correlation test for publication bias
    • 1:STN:280:DyaK2Mzgs1GrtQ%3D%3D 7786990
    • Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088-101.
    • (1994) Biometrics , vol.50 , Issue.4 , pp. 1088-1101
    • Begg, C.B.1    Mazumdar, M.2
  • 16
    • 0030922816 scopus 로고    scopus 로고
    • Bias in meta-analysis detected by a simple, graphical test
    • 1:STN:280:DyaK2svls1KjtA%3D%3D
    • Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res). 1997;315(7109):629-34.
    • (1997) BMJ (Clin Res) , vol.315 , Issue.7109 , pp. 629-634
    • Egger, M.1    Davey Smith, G.2    Schneider, M.3    Minder, C.4
  • 17
    • 0038207859 scopus 로고    scopus 로고
    • Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients
    • 1:CAS:528:DC%2BD3sXmvFWntLc%3D 14624713
    • Camps C, Sarries C, Roig B, Sanchez JJ, Queralt C, Sancho E, et al. Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients. Clin Lung Cancer. 2003;4(4):237-41.
    • (2003) Clin Lung Cancer , vol.4 , Issue.4 , pp. 237-241
    • Camps, C.1    Sarries, C.2    Roig, B.3    Sanchez, J.J.4    Queralt, C.5    Sancho, E.6
  • 18
    • 4444256594 scopus 로고    scopus 로고
    • Single nucleotide polymorphisms and outcome in docetaxel-cisplatin- treated advanced non-small-cell lung cancer
    • 10.1093/annonc/mdh319 1:STN:280:DC%2BD2cznt1Wmtw%3D%3D
    • Isla D, Sarries C, Rosell R, Alonso G, Domine M, Taron M, et al. Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer. Anna Oncol Off J Eur Soc Med Oncol ESMO. 2004;15(8):1194-203. doi: 10.1093/annonc/mdh319.
    • (2004) Anna Oncol off J Eur Soc Med Oncol ESMO , vol.15 , Issue.8 , pp. 1194-1203
    • Isla, D.1    Sarries, C.2    Rosell, R.3    Alonso, G.4    Domine, M.5    Taron, M.6
  • 19
    • 33645298447 scopus 로고    scopus 로고
    • Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients
    • 10.1093/annonc/mdj135
    • de las Penas R, Sanchez-Ronco M, Alberola V, Taron M, Camps C, Garcia-Carbonero R, et al. Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2006;17(4):668-75. doi: 10.1093/annonc/mdj135.
    • (2006) Ann Oncol off J Eur Soc Med Oncol ESMO , vol.17 , Issue.4 , pp. 668-675
    • De Las Penas, R.1    Sanchez-Ronco, M.2    Alberola, V.3    Taron, M.4    Camps, C.5    Garcia-Carbonero, R.6
  • 20
    • 78650944117 scopus 로고    scopus 로고
    • Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine
    • 10.1016/j.lungcan.2010.05.005 1:STN:280:DC%2BC3M7ksV2isA%3D%3D
    • Vinolas N, Provencio M, Reguart N, Cardenal F, Alberola V, Sanchez-Torres JM, et al. Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine. Lung Cancer (Amst Neth). 2011;71(2):191-8. doi: 10.1016/j.lungcan.2010.05.005.
    • (2011) Lung Cancer (Amst Neth) , vol.71 , Issue.2 , pp. 191-198
    • Vinolas, N.1    Provencio, M.2    Reguart, N.3    Cardenal, F.4    Alberola, V.5    Sanchez-Torres, J.M.6
  • 21
    • 84871204409 scopus 로고    scopus 로고
    • Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer
    • 10.1007/s00280-012-1985-9 1:CAS:528:DC%2BC38Xhslaqur%2FO 23053267
    • Provencio M, Camps C, Cobo M, De las Penas R, Massuti B, Blanco R, et al. Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer. Cancer Chemother Pharmacol. 2012;70(6):883-90. doi: 10.1007/s00280-012-1985-9.
    • (2012) Cancer Chemother Pharmacol , vol.70 , Issue.6 , pp. 883-890
    • Provencio, M.1    Camps, C.2    Cobo, M.3    De Las Penas, R.4    Massuti, B.5    Blanco, R.6
  • 22
    • 79960360304 scopus 로고    scopus 로고
    • Chemotherapy-induced neutropenia does not correlate with DNA repair gene polymorphisms and treatment efficacy in advanced non-small-cell lung cancer patients
    • 10.1016/j.cllc.2011.03.023 1:CAS:528:DC%2BC3MXhtlKjurrO 21726821
    • Iranzo V, Sirera R, Bremnes RM, Blasco A, Jantus-Lewintre E, Taron M, et al. Chemotherapy-induced neutropenia does not correlate with DNA repair gene polymorphisms and treatment efficacy in advanced non-small-cell lung cancer patients. Clin Lung Cancer. 2011;12(4):224-30. doi: 10.1016/j.cllc.2011.03.023.
    • (2011) Clin Lung Cancer , vol.12 , Issue.4 , pp. 224-230
    • Iranzo, V.1    Sirera, R.2    Bremnes, R.M.3    Blasco, A.4    Jantus-Lewintre, E.5    Taron, M.6
  • 23
    • 41549095093 scopus 로고    scopus 로고
    • Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients
    • 10.1158/1078-0432.ccr-07-1364 1:CAS:528:DC%2BD1cXjtleju78%3D
    • Tibaldi C, Giovannetti E, Vasile E, Mey V, Laan AC, Nannizzi S, et al. Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. Clinical Cancer Res Off J Am Assoc Cancer Res. 2008;14(6):1797-803. doi: 10.1158/1078-0432.ccr-07-1364.
    • (2008) Clinical Cancer Res off J Am Assoc Cancer Res , vol.14 , Issue.6 , pp. 1797-1803
    • Tibaldi, C.1    Giovannetti, E.2    Vasile, E.3    Mey, V.4    Laan, A.C.5    Nannizzi, S.6
  • 24
    • 81755185463 scopus 로고    scopus 로고
    • Association of cytidine deaminase and xeroderma pigmentosum group D polymorphisms with response, toxicity, and survival in cisplatin/gemcitabine- treated advanced non-small cell lung cancer patients
    • 10.1097/JTO.0b013e3182307e1f
    • Ludovini V, Floriani I, Pistola L, Minotti V, Meacci M, Chiari R, et al. Association of cytidine deaminase and xeroderma pigmentosum group D polymorphisms with response, toxicity, and survival in cisplatin/gemcitabine- treated advanced non-small cell lung cancer patients. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2011;6(12):2018-26. doi: 10.1097/JTO. 0b013e3182307e1f.
    • (2011) J Thorac Oncol off Publ Int Assoc Study Lung Cancer , vol.6 , Issue.12 , pp. 2018-2026
    • Ludovini, V.1    Floriani, I.2    Pistola, L.3    Minotti, V.4    Meacci, M.5    Chiari, R.6
  • 25
    • 84877064645 scopus 로고    scopus 로고
    • ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin
    • 10.1038/bjc.2013.127 1:CAS:528:DC%2BC3sXntVOrurY%3D 23549037
    • Tiseo M, Bordi P, Bortesi B, Boni L, Boni C, Baldini E, et al. ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin. Br J Cancer. 2013;108(8):1695-703. doi: 10.1038/bjc.2013.127.
    • (2013) Br J Cancer , vol.108 , Issue.8 , pp. 1695-1703
    • Tiseo, M.1    Bordi, P.2    Bortesi, B.3    Boni, L.4    Boni, C.5    Baldini, E.6
  • 26
    • 4143051317 scopus 로고    scopus 로고
    • Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
    • 10.1158/1078-0432.ccr-04-0247 1:CAS:528:DC%2BD2cXmtlSitr4%3D
    • Zhou W, Gurubhagavatula S, Liu G, Park S, Neuberg DS, Wain JC, et al. Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res Off J Am Assoc Cancer Res. 2004;10(15):4939-43. doi: 10.1158/1078-0432.ccr-04-0247.
    • (2004) Clin Cancer Res off J Am Assoc Cancer Res , vol.10 , Issue.15 , pp. 4939-4943
    • Zhou, W.1    Gurubhagavatula, S.2    Liu, G.3    Park, S.4    Neuberg, D.S.5    Wain, J.C.6
  • 27
    • 4344567395 scopus 로고    scopus 로고
    • XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy
    • 10.1200/jco.2004.08.067 1:CAS:528:DC%2BD2cXpsVWksLo%3D
    • Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC, et al. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol Off J Am Soc Clin Oncol. 2004;22(13):2594-601. doi: 10.1200/jco.2004.08.067.
    • (2004) J Clin Oncol off J Am Soc Clin Oncol , vol.22 , Issue.13 , pp. 2594-2601
    • Gurubhagavatula, S.1    Liu, G.2    Park, S.3    Zhou, W.4    Su, L.5    Wain, J.C.6
  • 28
    • 20044368468 scopus 로고    scopus 로고
    • Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients
    • 10.1158/1078-0432.ccr-04-1953 1:CAS:528:DC%2BD2MXhvVSrtr4%3D
    • Suk R, Gurubhagavatula S, Park S, Zhou W, Su L, Lynch TJ, et al. Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients. Clin Cancer Res Off J Am Assoc Cancer Res. 2005;11(4):1534-8. doi: 10.1158/1078-0432.ccr-04-1953.
    • (2005) Clin Cancer Res off J Am Assoc Cancer Res , vol.11 , Issue.4 , pp. 1534-1538
    • Suk, R.1    Gurubhagavatula, S.2    Park, S.3    Zhou, W.4    Su, L.5    Lynch, T.J.6
  • 29
    • 33646870784 scopus 로고    scopus 로고
    • Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapy in advanced nonsmall cell lung cancer
    • 10.1002/cncr.21885 1:CAS:528:DC%2BD28Xls1Sru74%3D 16649224
    • Booton R, Ward T, Heighway J, Taylor P, Power F, Ashcroft L, et al. Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapy in advanced nonsmall cell lung cancer. Cancer. 2006;106(11):2421-7. doi: 10.1002/cncr.21885.
    • (2006) Cancer , vol.106 , Issue.11 , pp. 2421-2427
    • Booton, R.1    Ward, T.2    Heighway, J.3    Taylor, P.4    Power, F.5    Ashcroft, L.6
  • 30
    • 65349117547 scopus 로고    scopus 로고
    • DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer
    • 10.3816/CLC.2009.n.015 1:CAS:528:DC%2BD1MXltFers7k%3D 19362955
    • Kalikaki A, Kanaki M, Vassalou H, Souglakos J, Voutsina A, Georgoulias V, et al. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer. Clin Lung Cancer. 2009;10(2):118-23. doi: 10.3816/CLC.2009.n.015.
    • (2009) Clin Lung Cancer , vol.10 , Issue.2 , pp. 118-123
    • Kalikaki, A.1    Kanaki, M.2    Vassalou, H.3    Souglakos, J.4    Voutsina, A.5    Georgoulias, V.6
  • 31
    • 84860277658 scopus 로고    scopus 로고
    • Predictive value of ERCC1 single-nucleotide polymorphism in patients receiving platinum-based chemotherapy for locally-advanced and advanced non-small cell lung cancer - A pilot study
    • 10.2478/18700 1:CAS:528:DC%2BC38Xhs1emtbnI
    • Krawczyk P, Wojas-Krawczyk K, Mlak R, Kucharczyk T, Biernacka B, Milanowski J. Predictive value of ERCC1 single-nucleotide polymorphism in patients receiving platinum-based chemotherapy for locally-advanced and advanced non-small cell lung cancer - a pilot study. Folia Histochem Cytobiol Pol Acad Sci Pol Histochem Cytochem Soc. 2012;50(1):80-6. doi: 10.2478/18700.
    • (2012) Folia Histochem Cytobiol Pol Acad Sci Pol Histochem Cytochem Soc , vol.50 , Issue.1 , pp. 80-86
    • Krawczyk, P.1    Wojas-Krawczyk, K.2    Mlak, R.3    Kucharczyk, T.4    Biernacka, B.5    Milanowski, J.6
  • 32
    • 84860216677 scopus 로고    scopus 로고
    • Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: A prospective clinical study
    • 10.1002/cncr.26562 1:CAS:528:DC%2BC38XlslyitLY%3D 22031394
    • Joerger M, Burgers SA, Baas P, Smit EF, Haitjema TJ, Bard MP, et al. Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study. Cancer. 2012;118(9):2466-75. doi: 10.1002/cncr.26562.
    • (2012) Cancer , vol.118 , Issue.9 , pp. 2466-2475
    • Joerger, M.1    Burgers, S.A.2    Baas, P.3    Smit, E.F.4    Haitjema, T.J.5    Bard, M.P.6
  • 33
    • 2342616723 scopus 로고    scopus 로고
    • Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy
    • 10.1016/j.lungcan.2003.11.019
    • Ryu JS, Hong YC, Han HS, Lee JE, Kim S, Park YM, et al. Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy. Lung Cancer (Amst Neth). 2004;44(3):311-6. doi: 10.1016/j.lungcan.2003.11.019.
    • (2004) Lung Cancer (Amst Neth) , vol.44 , Issue.3 , pp. 311-316
    • Ryu, J.S.1    Hong, Y.C.2    Han, H.S.3    Lee, J.E.4    Kim, S.5    Park, Y.M.6
  • 34
    • 79951875424 scopus 로고    scopus 로고
    • Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer
    • 10.1200/jco.2010.30.5334 1:CAS:528:DC%2BC3MXisFCntw%3D%3D
    • Shiraishi K, Kohno T, Tanai C, Goto Y, Kuchiba A, Yamamoto S, et al. Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(33):4945-52. doi: 10.1200/jco.2010.30.5334.
    • (2010) J Clin Oncol off J Am Soc Clin Oncol , vol.28 , Issue.33 , pp. 4945-4952
    • Shiraishi, K.1    Kohno, T.2    Tanai, C.3    Goto, Y.4    Kuchiba, A.5    Yamamoto, S.6
  • 35
    • 70249137644 scopus 로고    scopus 로고
    • Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: A model for assessing population-related pharmacogenomics
    • 10.1200/jco.2008.20.8793 1:CAS:528:DC%2BD1MXhtVSqtLjJ
    • Gandara DR, Kawaguchi T, Crowley J, Moon J, Furuse K, Kawahara M, et al. Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27(21):3540-6. doi: 10.1200/jco.2008.20.8793.
    • (2009) J Clin Oncol off J Am Soc Clin Oncol , vol.27 , Issue.21 , pp. 3540-3546
    • Gandara, D.R.1    Kawaguchi, T.2    Crowley, J.3    Moon, J.4    Furuse, K.5    Kawahara, M.6
  • 36
    • 34247172071 scopus 로고    scopus 로고
    • Genetic polymorphisms and treatment response in advanced non-small cell lung cancer
    • 10.1016/j.lungcan.2006.12.002
    • Su D, Ma S, Liu P, Jiang Z, Lv W, Zhang Y, et al. Genetic polymorphisms and treatment response in advanced non-small cell lung cancer. Lung Cancer (Amst Neth). 2007;56(2):281-8. doi: 10.1016/j.lungcan.2006.12.002.
    • (2007) Lung Cancer (Amst Neth) , vol.56 , Issue.2 , pp. 281-288
    • Su, D.1    Ma, S.2    Liu, P.3    Jiang, Z.4    Lv, W.5    Zhang, Y.6
  • 37
    • 77952315609 scopus 로고    scopus 로고
    • Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers
    • Yao CY, Huang XE, Li C, Shen HB, Shi MQ, Feng JF, et al. Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers. Asian Pac J Cancer Prev APJCP. 2009;10(5):859-64.
    • (2009) Asian Pac J Cancer Prev APJCP , vol.10 , Issue.5 , pp. 859-864
    • Yao, C.Y.1    Huang, X.E.2    Li, C.3    Shen, H.B.4    Shi, M.Q.5    Feng, J.F.6
  • 38
    • 84861846758 scopus 로고    scopus 로고
    • Potentially functional polymorphisms in DNA repair genes and non-small-cell lung cancer survival: A pathway-based analysis
    • 10.1002/mc.20819 1:CAS:528:DC%2BC38XnvFOqtr8%3D 21739480
    • Dong J, Hu Z, Shu Y, Pan S, Chen W, Wang Y, et al. Potentially functional polymorphisms in DNA repair genes and non-small-cell lung cancer survival: a pathway-based analysis. Mol Carcinog. 2012;51(7):546-52. doi: 10.1002/mc.20819.
    • (2012) Mol Carcinog , vol.51 , Issue.7 , pp. 546-552
    • Dong, J.1    Hu, Z.2    Shu, Y.3    Pan, S.4    Chen, W.5    Wang, Y.6
  • 39
    • 84879876808 scopus 로고    scopus 로고
    • Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population
    • 10.1631/jzus.B1200101 1:CAS:528:DC%2BC3sXjvFekur4%3D 3596571 23463763
    • Hong W, Wang K, Zhang YP, Kou JY, Hong D, Su D, et al. Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population. J Zhejiang Univ Sci B. 2013;14(3):207-15. doi: 10.1631/jzus.B1200101.
    • (2013) J Zhejiang Univ Sci B , vol.14 , Issue.3 , pp. 207-215
    • Hong, W.1    Wang, K.2    Zhang, Y.P.3    Kou, J.Y.4    Hong, D.5    Su, D.6
  • 40
    • 79958102953 scopus 로고    scopus 로고
    • Lack of correlation between ERCC1 (C8092A) single nucleotide polymorphism and efficacy/toxicity of platinum based chemotherapy in Chinese patients with advanced non-small cell lung cancer
    • 10.2478/v10039-011-0013-3 1:CAS:528:DC%2BC3MXht1ejsLbF 21536539
    • KimCurran V, Zhou C, Schmid-Bindert G, Shengxiang R, Zhou S, Zhang L, et al. Lack of correlation between ERCC1 (C8092A) single nucleotide polymorphism and efficacy/toxicity of platinum based chemotherapy in Chinese patients with advanced non-small cell lung cancer. Adv Med Sci. 2011;56(1):30-8. doi: 10.2478/v10039-011-0013-3.
    • (2011) Adv Med Sci , vol.56 , Issue.1 , pp. 30-38
    • Kimcurran, V.1    Zhou, C.2    Schmid-Bindert, G.3    Shengxiang, R.4    Zhou, S.5    Zhang, L.6
  • 41
    • 83555173540 scopus 로고    scopus 로고
    • Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy
    • 10.1016/j.lungcan.2011.05.023
    • Ren S, Zhou S, Wu F, Zhang L, Li X, Zhang J, et al. Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy. Lung Cancer (Amst Neth). 2012;75(1):102-9. doi: 10.1016/j.lungcan.2011.05.023.
    • (2012) Lung Cancer (Amst Neth) , vol.75 , Issue.1 , pp. 102-109
    • Ren, S.1    Zhou, S.2    Wu, F.3    Zhang, L.4    Li, X.5    Zhang, J.6
  • 42
    • 79957745242 scopus 로고    scopus 로고
    • Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy
    • 10.1016/j.lungcan.2010.11.004
    • Liu L, Yuan P, Wu C, Zhang X, Wang F, Guo H, et al. Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer (Amst Neth). 2011;73(1):110-5. doi: 10.1016/j.lungcan.2010.11.004.
    • (2011) Lung Cancer (Amst Neth) , vol.73 , Issue.1 , pp. 110-115
    • Liu, L.1    Yuan, P.2    Wu, C.3    Zhang, X.4    Wang, F.5    Guo, H.6
  • 43
    • 34548446805 scopus 로고    scopus 로고
    • Correlation of genetic polymorphisms in nucleotide excision repair system to sensitivity of advanced non-small cell lung cancer patients to platinum-based chemotherapy
    • 1:CAS:528:DC%2BD28Xht1Kjsb3M
    • Yuan P, Miao XP, Zhang XM, Wang ZH, Tan W, Zhang XR, et al. Correlation of genetic polymorphisms in nucleotide excision repair system to sensitivity of advanced non-small cell lung cancer patients to platinum-based chemotherapy. Ai zheng Aizheng Chin J Cancer. 2005;24(12):1510-3.
    • (2005) Ai Zheng Aizheng Chin J Cancer , vol.24 , Issue.12 , pp. 1510-1513
    • Yuan, P.1    Miao, X.P.2    Zhang, X.M.3    Wang, Z.H.4    Tan, W.5    Zhang, X.R.6
  • 44
    • 77649238161 scopus 로고    scopus 로고
    • Association of MDR1 and ERCC1 polymorphisms with response and toxicity to cisplatin-based chemotherapy in non-small-cell lung cancer patients
    • 10.1016/j.ijheh.2010.01.004 1:CAS:528:DC%2BC3cXnsVeht74%3D 20189873
    • Chen S, Huo X, Lin Y, Ban H, Li W, Zhang B, et al. Association of MDR1 and ERCC1 polymorphisms with response and toxicity to cisplatin-based chemotherapy in non-small-cell lung cancer patients. Int J Hyg Environ Health. 2010;213(2):140-5. doi: 10.1016/j.ijheh.2010.01.004.
    • (2010) Int J Hyg Environ Health , vol.213 , Issue.2 , pp. 140-145
    • Chen, S.1    Huo, X.2    Lin, Y.3    Ban, H.4    Li, W.5    Zhang, B.6
  • 45
    • 79958824467 scopus 로고    scopus 로고
    • Lack of any relationship between chemotherapy toxicity in non-small cell lung cancer cases and polymorphisms in XRCC1 codon 399 or XPD codon 751
    • Li Y, Huang XE, Jin GF, Shen HB, Xu L. Lack of any relationship between chemotherapy toxicity in non-small cell lung cancer cases and polymorphisms in XRCC1 codon 399 or XPD codon 751. Asian Pac J Cancer Prev APJCP. 2011;12(3):739-42.
    • (2011) Asian Pac J Cancer Prev APJCP , vol.12 , Issue.3 , pp. 739-742
    • Li, Y.1    Huang, X.E.2    Jin, G.F.3    Shen, H.B.4    Xu, L.5
  • 46
    • 84884132007 scopus 로고    scopus 로고
    • Predictive effect of XPA and XPD polymorphisms on survival of advanced NSCLC patients treated with platinum-based chemotherapy: A three-dimensional (3-D), polyacrylamide gel-based DNA microarray method
    • 10.7785/tcrt.2012.500337
    • Cheng H, Qin Q, Sun X, Li F, Sun N, Cheng L, et al. Predictive effect of XPA and XPD polymorphisms on survival of advanced NSCLC patients treated with platinum-based chemotherapy: a three-dimensional (3-D), polyacrylamide gel-based DNA microarray method. Technol Cancer Res Treat. 2013. doi: 10.7785/tcrt.2012.500337.
    • (2013) Technol Cancer Res Treat
    • Cheng, H.1    Qin, Q.2    Sun, X.3    Li, F.4    Sun, N.5    Cheng, L.6
  • 47
    • 77951574462 scopus 로고    scopus 로고
    • Association between polymorphisms of ERCC1 and response in patients with advanced non-small cell lung cancer receiving cisplatin-based chemotherapy
    • 1:CAS:528:DC%2BC3cXmtlShsbY%3D
    • Wang J, Zhang Q, Zhang H, Wang Q, Yang X, Gu Y, et al. Association between polymorphisms of ERCC1 and response in patients with advanced non-small cell lung cancer receiving cisplatin-based chemotherapy. Zhongguo fei ai za zhi Chin J Lung Cancer. 2010;13(4):337-41.
    • (2010) Zhongguo Fei Ai Za Zhi Chin J Lung Cancer , vol.13 , Issue.4 , pp. 337-341
    • Wang, J.1    Zhang, Q.2    Zhang, H.3    Wang, Q.4    Yang, X.5    Gu, Y.6
  • 48
    • 84859047794 scopus 로고    scopus 로고
    • Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients
    • 10.1371/journal.pone.0033200 1:CAS:528:DC%2BC38XlsFamur4%3D 3315552 22479369
    • Wu W, Li H, Wang H, Zhao X, Gao Z, Qiao R, et al. Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients. PloS one. 2012;7(3):e33200. doi: 10.1371/journal.pone.0033200.
    • (2012) PloS One , vol.7 , Issue.3 , pp. 33200
    • Wu, W.1    Li, H.2    Wang, H.3    Zhao, X.4    Gao, Z.5    Qiao, R.6
  • 49
    • 66649120041 scopus 로고    scopus 로고
    • Association of XPD polymorphisms with severe toxicity in non-small cell lung cancer patients in a Chinese population
    • 10.1158/1078-0432.ccr-08-2715 1:CAS:528:DC%2BD1MXmsFOju7k%3D
    • Wu W, Zhang W, Qiao R, Chen D, Wang H, Wang Y, et al. Association of XPD polymorphisms with severe toxicity in non-small cell lung cancer patients in a Chinese population. Clin Cancer Res Off J Am Assoc Cancer Res. 2009;15(11):3889-95. doi: 10.1158/1078-0432.ccr-08-2715.
    • (2009) Clin Cancer Res off J Am Assoc Cancer Res , vol.15 , Issue.11 , pp. 3889-3895
    • Wu, W.1    Zhang, W.2    Qiao, R.3    Chen, D.4    Wang, H.5    Wang, Y.6
  • 50
    • 84874043473 scopus 로고    scopus 로고
    • Predictive role of ERCC1 and XPD genetic polymorphisms in survival of Chinese non-small cell lung cancer patients receiving chemotherapy
    • Zhang ZY, Tian X, Wu R, Liang Y, Jin XY. Predictive role of ERCC1 and XPD genetic polymorphisms in survival of Chinese non-small cell lung cancer patients receiving chemotherapy. Asian Pac J Cancer Prev APJCP. 2012;13(6):2583-6.
    • (2012) Asian Pac J Cancer Prev APJCP , vol.13 , Issue.6 , pp. 2583-2586
    • Zhang, Z.Y.1    Tian, X.2    Wu, R.3    Liang, Y.4    Jin, X.Y.5
  • 51
    • 84857039539 scopus 로고    scopus 로고
    • A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with late-stage non-small cell lung cancer
    • 10.1007/s00432-011-1090-1 1:CAS:528:DC%2BC38XpslOmuw%3D%3D 22102173
    • Cheng J, Ha M, Wang Y, Sun J, Chen J, Tong C. A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with late-stage non-small cell lung cancer. J Cancer Res Clin Oncol. 2012;138(2):231-8. doi: 10.1007/s00432-011-1090-1.
    • (2012) J Cancer Res Clin Oncol , vol.138 , Issue.2 , pp. 231-238
    • Cheng, J.1    Ha, M.2    Wang, Y.3    Sun, J.4    Chen, J.5    Tong, C.6
  • 52
    • 84877127317 scopus 로고    scopus 로고
    • Common variations of DNA repair genes are associated with response to platinum-based chemotherapy in NSCLCs
    • Li XD, Han JC, Zhang YJ, Li HB, Wu XY. Common variations of DNA repair genes are associated with response to platinum-based chemotherapy in NSCLCs. Asian Pac J Cancer Prev APJCP. 2013;14(1):145-8.
    • (2013) Asian Pac J Cancer Prev APJCP , vol.14 , Issue.1 , pp. 145-148
    • Li, X.D.1    Han, J.C.2    Zhang, Y.J.3    Li, H.B.4    Wu, X.Y.5
  • 53
    • 84861333516 scopus 로고    scopus 로고
    • Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum
    • 10.1097/JTO.0b013e31824fe98c 1:CAS:528:DC%2BC38XhtVShtbjJ
    • Liao WY, Shih JY, Chang GC, Cheng YK, Yang JC, Chen YM, et al. Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2012;7(6):973-81. doi: 10.1097/JTO. 0b013e31824fe98c.
    • (2012) J Thorac Oncol off Publ Int Assoc Study Lung Cancer , vol.7 , Issue.6 , pp. 973-981
    • Liao, W.Y.1    Shih, J.Y.2    Chang, G.C.3    Cheng, Y.K.4    Yang, J.C.5    Chen, Y.M.6
  • 54
    • 84898834718 scopus 로고    scopus 로고
    • Single nucleotide polymorphism in ERCC1 C118T predicts the outcome of NSCLC patients receiving platinum-based chemotherapy
    • 1:CAS:528:DC%2BC3MXhs1aqtbjI
    • Qian XP, Liu BR, Yan WY, Wang LF, Wei J, Xie L, et al. Single nucleotide polymorphism in ERCC1 C118T predicts the outcome of NSCLC patients receiving platinum-based chemotherapy. Mod Oncol. 2011;19(10):1997-2001.
    • (2011) Mod Oncol , vol.19 , Issue.10 , pp. 1997-2001
    • Qian, X.P.1    Liu, B.R.2    Yan, W.Y.3    Wang, L.F.4    Wei, J.5    Xie, L.6
  • 55
    • 84862632431 scopus 로고    scopus 로고
    • Sensitivity relationship of ERCC1 and XRCC1 genetic polymorphism on response of platinum-based chemotherapy in advanced NSCLC
    • 1:CAS:528:DC%2BC38XhtVems77I
    • Xu CA, Li Q, Wang XJ, Li L. Sensitivity relationship of ERCC1 and XRCC1 genetic polymorphism on response of platinum-based chemotherapy in advanced NSCLC. J Prac Oncol. 2012;27(3):245-50.
    • (2012) J Prac Oncol , vol.27 , Issue.3 , pp. 245-250
    • Xu, C.A.1    Li, Q.2    Wang, X.J.3    Li, L.4
  • 56
    • 84922981906 scopus 로고    scopus 로고
    • ERCC1 and XRCC1 gene polymorphisms and clinical response to platinum-based chemotherapy in advanced non-small cell lung cancer
    • Han Y, Liang J, Lv HY, Yao RY, Jiang T, Zhou F, et al. ERCC1 and XRCC1 gene polymorphisms and clinical response to platinum-based chemotherapy in advanced non-small cell lung cancer. Chin J Prac Int Med. 2011;31(8):638-9.
    • (2011) Chin J Prac Int Med , vol.31 , Issue.8 , pp. 638-639
    • Han, Y.1    Liang, J.2    Lv, H.Y.3    Yao, R.Y.4    Jiang, T.5    Zhou, F.6
  • 57
    • 84898807446 scopus 로고    scopus 로고
    • Polymorphisms in XPD751 gene and sensitivity to gemcitabine /cisplatin chemotherapy in advanced stage of non-small-cell lung cancer
    • 1:CAS:528:DC%2BD1MXmt1yqsb4%3D
    • Ding ZH, Xu L, Gao CM, Wu JZ, Shi MQ, Feng JF. Polymorphisms in XPD751 gene and sensitivity to gemcitabine /cisplatin chemotherapy in advanced stage of non-small-cell lung cancer. Acta Univ Med Nanjing. 2008;28(4):457-61.
    • (2008) Acta Univ Med Nanjing , vol.28 , Issue.4 , pp. 457-461
    • Ding, Z.H.1    Xu, L.2    Gao, C.M.3    Wu, J.Z.4    Shi, M.Q.5    Feng, J.F.6
  • 58
    • 68949219423 scopus 로고    scopus 로고
    • Study on ERCC1, XPD and XPA polymorphisms for prediction of platinum-based chemotherapy sensitivity in non-small cell lung cancer
    • 1:CAS:528:DC%2BD1MXhtVGksb%2FP
    • Liu YF, Guan XX, Chen LB, Chen YT. Study on ERCC1, XPD and XPA polymorphisms for prediction of platinum-based chemotherapy sensitivity in non-small cell lung cancer. Chin J Cancer Prev Treat. 2008;15(17):1285-8.
    • (2008) Chin J Cancer Prev Treat , vol.15 , Issue.17 , pp. 1285-1288
    • Liu, Y.F.1    Guan, X.X.2    Chen, L.B.3    Chen, Y.T.4
  • 59
    • 84862822867 scopus 로고    scopus 로고
    • Singlenueleotide polymorphismsin in XRCC1, XPD and platinum prognosis in non-small-cell lung cancer patients
    • Liu XZ, Qian XP, Liu BR, Hu WJ, Wang LF, Wei J, et al. Singlenueleotide polymorphismsin in XRCC1, XPD and platinum prognosis in non-small-cell lung cancer patients. J Clin Med Prac. 2008;12(5):7-11.
    • (2008) J Clin Med Prac , vol.12 , Issue.5 , pp. 7-11
    • Liu, X.Z.1    Qian, X.P.2    Liu, B.R.3    Hu, W.J.4    Wang, L.F.5    Wei, J.6
  • 60
    • 84898814286 scopus 로고    scopus 로고
    • The ERCC1 codon118 gene expression significance in predicting the three generations of platinum containing regimen in advanced non-small cell lung cancer
    • 1:CAS:528:DC%2BC38XntFKgurg%3D
    • Wang SH, Jiang CF. The ERCC1 codon118 gene expression significance in predicting the three generations of platinum containing regimen in advanced non-small cell lung cancer. Chin J Clin Oncol Rehabil. 2012;19(5):388-90.
    • (2012) Chin J Clin Oncol Rehabil , vol.19 , Issue.5 , pp. 388-390
    • Wang, S.H.1    Jiang, C.F.2
  • 61
    • 79952248780 scopus 로고    scopus 로고
    • XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer
    • Song DG, Liu J, Wang ZH, Song B, Li CZ. XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer. Chin J Gerontol. 2007;27:1684-6.
    • (2007) Chin J Gerontol , vol.27 , pp. 1684-1686
    • Song, D.G.1    Liu, J.2    Wang, Z.H.3    Song, B.4    Li, C.Z.5
  • 62
    • 79952250345 scopus 로고    scopus 로고
    • Relationship of XRCC1 and XPD gene polymorphisms with chemosensitivity to platinum-based chemotherapy in advanced non-small cell lung cancer
    • 1:CAS:528:DC%2BD1cXhtlartrnO
    • Fan H, Huang XE, Zhang Q, Gao LL, Xu L, Jin GF, et al. Relationship of XRCC1 and XPD gene polymorphisms with chemosensitivity to platinum-based chemotherapy in advanced non-small cell lung cancer. Pract Geriatr. 2008;22(4):306-14.
    • (2008) Pract Geriatr , vol.22 , Issue.4 , pp. 306-314
    • Fan, H.1    Huang, X.E.2    Zhang, Q.3    Gao, L.L.4    Xu, L.5    Jin, G.F.6
  • 63
    • 84886779606 scopus 로고    scopus 로고
    • Single nucleotide polymorphisms in DNA repair ERCC1 predict clinical response to platinum-based chemotherapy in non-small cell lung cancer
    • 1:CAS:528:DC%2BC3MXivVKrtA%3D%3D
    • Ren BH, Yang X, Li M, Jiang F, Yin R, Xu L. Single nucleotide polymorphisms in DNA repair ERCC1 predict clinical response to platinum-based chemotherapy in non-small cell lung cancer. Chin J Exp Surg. 2010;27(9):1200-2.
    • (2010) Chin J Exp Surg , vol.27 , Issue.9 , pp. 1200-1202
    • Ren, B.H.1    Yang, X.2    Li, M.3    Jiang, F.4    Yin, R.5    Xu, L.6
  • 64
    • 33846996411 scopus 로고    scopus 로고
    • Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients
    • 10.1385/mo:23:4:489 1:CAS:528:DC%2BD2sXht1antLg%3D
    • Park SY, Hong YC, Kim JH, Kwak SM, Cho JH, Lee HL, et al. Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients. Med Oncol (Northwood Lond Engl). 2006;23(4):489-98. doi: 10.1385/mo:23:4:489.
    • (2006) Med Oncol (Northwood Lond Engl) , vol.23 , Issue.4 , pp. 489-498
    • Park, S.Y.1    Hong, Y.C.2    Kim, J.H.3    Kwak, S.M.4    Cho, J.H.5    Lee, H.L.6
  • 65
    • 79959918475 scopus 로고    scopus 로고
    • DNA repair gene polymorphisms and benefit from gefitinib in never-smokers with lung adenocarcinoma
    • 10.1002/cncr.25863 1:CAS:528:DC%2BC3MXot1ansLc%3D 21264830
    • Han JY, Yoon KA, Park JH, Lee YJ, Lee GK, Han JH, et al. DNA repair gene polymorphisms and benefit from gefitinib in never-smokers with lung adenocarcinoma. Cancer. 2011;117(14):3201-8. doi: 10.1002/cncr.25863.
    • (2011) Cancer , vol.117 , Issue.14 , pp. 3201-3208
    • Han, J.Y.1    Yoon, K.A.2    Park, J.H.3    Lee, Y.J.4    Lee, G.K.5    Han, J.H.6
  • 66
    • 79955848417 scopus 로고    scopus 로고
    • Excision repair cross complementation group 1 polymorphisms predict overall survival after platinum-based chemotherapy for completely resected non-small-cell lung cancer
    • 10.1016/j.jss.2009.09.006 1:CAS:528:DC%2BC3MXlslyhs7g%3D 20070981
    • Okuda K, Sasaki H, Hikosaka Y, Kawano O, Yukiue H, Yano M, et al. Excision repair cross complementation group 1 polymorphisms predict overall survival after platinum-based chemotherapy for completely resected non-small-cell lung cancer. J Surg Res. 2011;168(2):206-12. doi: 10.1016/j.jss.2009.09.006.
    • (2011) J Surg Res , vol.168 , Issue.2 , pp. 206-212
    • Okuda, K.1    Sasaki, H.2    Hikosaka, Y.3    Kawano, O.4    Yukiue, H.5    Yano, M.6
  • 67
    • 84872775195 scopus 로고    scopus 로고
    • DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy
    • 10.1007/s12032-011-0033-7 1:CAS:528:DC%2BC38Xht1GrsrnP
    • Li D, Zhou Q, Liu Y, Yang Y, Li Q. DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy. Med Oncol (Northwood, London, England). 2012;29(3):1622-8. doi: 10.1007/s12032-011-0033-7.
    • (2012) Med Oncol (Northwood, London, England) , vol.29 , Issue.3 , pp. 1622-1628
    • Li, D.1    Zhou, Q.2    Liu, Y.3    Yang, Y.4    Li, Q.5
  • 68
    • 79960543781 scopus 로고    scopus 로고
    • Role of DNA repair gene polymorphisms in the efficiency of platinum-based adjuvant chemotherapy for non-small cell lung cancer
    • 10.2165/11591140-000000000-00000 1:CAS:528:DC%2BC3MXhtFyqtr%2FK 21766907
    • Mathiaux J, Le Morvan V, Pulido M, Jougon J, Begueret H, Robert J. Role of DNA repair gene polymorphisms in the efficiency of platinum-based adjuvant chemotherapy for non-small cell lung cancer. Mol Diagn Ther. 2011;15(3):159-66. doi: 10.2165/11591140-000000000-00000.
    • (2011) Mol Diagn Ther , vol.15 , Issue.3 , pp. 159-166
    • Mathiaux, J.1    Le Morvan, V.2    Pulido, M.3    Jougon, J.4    Begueret, H.5    Robert, J.6
  • 69
    • 84864495074 scopus 로고    scopus 로고
    • Influence of DNA repair gene polymorphisms on prognosis in inoperable non-small cell lung cancer patients treated with radiotherapy and platinum-based chemotherapy
    • 10.1002/ijc.27596 1:CAS:528:DC%2BC38XmvVKlsbs%3D
    • Butkiewicz D, Drosik A, Suwinski R, Krzesniak M, Rusin M, Kosarewicz A, et al. Influence of DNA repair gene polymorphisms on prognosis in inoperable non-small cell lung cancer patients treated with radiotherapy and platinum-based chemotherapy. Int J Cancer J Int Cancer. 2012;131(7):E1100-8. doi: 10.1002/ijc.27596.
    • (2012) Int J Cancer J Int Cancer , vol.131 , Issue.7 , pp. 1100-1108
    • Butkiewicz, D.1    Drosik, A.2    Suwinski, R.3    Krzesniak, M.4    Rusin, M.5    Kosarewicz, A.6
  • 70
    • 84898792778 scopus 로고    scopus 로고
    • Association study of ERCC1 and ERCC4 genetic polymorphism with response and survival in non-small cell lung cancer patients treated with cisplatin-based chemotherapy
    • Hua ZH, Fang WZ, Zhao ZQ, Xie FW, Ou-yang XN, Song HT. Association study of ERCC1 and ERCC4 genetic polymorphism with response and survival in non-small cell lung cancer patients treated with cisplatin-based chemotherapy. Chin J Clin Pharmacol Ther. 2011;16(7):772-8.
    • (2011) Chin J Clin Pharmacol Ther , vol.16 , Issue.7 , pp. 772-778
    • Hua, Z.H.1    Fang, W.Z.2    Zhao, Z.Q.3    Xie, F.W.4    Ou-Yang, X.N.5    Song, H.T.6
  • 71
    • 79952251471 scopus 로고    scopus 로고
    • Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: A systematic review and meta-analysis
    • 10.1007/s12032-010-9443-1 1:CAS:528:DC%2BC3MXisV2gsrc%3D
    • Wei SZ, Zhan P, Shi MQ, Shi Y, Qian Q, Yu LK, et al. Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis. Med Oncol (Northwood, London, England). 2011;28(1):315-21. doi: 10.1007/s12032-010-9443-1.
    • (2011) Med Oncol (Northwood, London, England) , vol.28 , Issue.1 , pp. 315-321
    • Wei, S.Z.1    Zhan, P.2    Shi, M.Q.3    Shi, Y.4    Qian, Q.5    Yu, L.K.6
  • 72
    • 80052755181 scopus 로고    scopus 로고
    • Polymorphisms of ERCC1 C118T/C8092A and MDR1 C3435T predict outcome of platinum-based chemotherapies in advanced non-small cell lung cancer: A meta-analysis
    • 10.1016/j.arcmed.2011.07.008 1:CAS:528:DC%2BC3MXhtFGnsb3E 21827803
    • Wei HB, Lu XS, Shang LH, Xu G, Hu J, Che DH, et al. Polymorphisms of ERCC1 C118T/C8092A and MDR1 C3435T predict outcome of platinum-based chemotherapies in advanced non-small cell lung cancer: a meta-analysis. Arch Med Res. 2011;42(5):412-20. doi: 10.1016/j.arcmed.2011.07.008.
    • (2011) Arch Med Res , vol.42 , Issue.5 , pp. 412-420
    • Wei, H.B.1    Lu, X.S.2    Shang, L.H.3    Xu, G.4    Hu, J.5    Che, D.H.6
  • 73
    • 85027922301 scopus 로고    scopus 로고
    • Pharmacogenetic role of ERCC1 genetic variants in treatment response of platinum-based chemotherapy among advanced non-small cell lung cancer patients
    • 10.1007/s13277-011-0314-y 1:CAS:528:DC%2BC38XmsF2ntbk%3D
    • Yu D, Shi J, Sun T, Du X, Liu L, Zhang X, et al. Pharmacogenetic role of ERCC1 genetic variants in treatment response of platinum-based chemotherapy among advanced non-small cell lung cancer patients. Tumour Biol J Int Soc Oncodevelop Biol Med. 2012;33(3):877-84. doi: 10.1007/s13277-011-0314-y.
    • (2012) Tumour Biol J Int Soc Oncodevelop Biol Med , vol.33 , Issue.3 , pp. 877-884
    • Yu, D.1    Shi, J.2    Sun, T.3    Du, X.4    Liu, L.5    Zhang, X.6
  • 74
    • 79955471779 scopus 로고    scopus 로고
    • No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: A meta-analysis
    • 10.1016/j.lungcan.2010.10.011
    • Yin M, Yan J, Voutsina A, Tibaldi C, Christiani DC, Heist RS, et al. No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: a meta-analysis. Lung Cancer (Amst Neth). 2011;72(3):370-7. doi: 10.1016/j.lungcan.2010.10.011.
    • (2011) Lung Cancer (Amst Neth) , vol.72 , Issue.3 , pp. 370-377
    • Yin, M.1    Yan, J.2    Voutsina, A.3    Tibaldi, C.4    Christiani, D.C.5    Heist, R.S.6
  • 75
    • 84880750582 scopus 로고    scopus 로고
    • Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: A pooled analysis based on 39 reports
    • 10.1016/j.gene.2013.05.021 3642073
    • Xu TP, Shen H, Liu LX, Shu YQ. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports. Gene. 2013. doi: 10.1016/j.gene.2013.05.021.
    • (2013) Gene
    • Xu, T.P.1    Shen, H.2    Liu, L.X.3    Shu, Y.Q.4
  • 76
    • 77957696698 scopus 로고    scopus 로고
    • Predictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced NSCLC patients
    • 10.1093/jjco/hyq071
    • Zhou C, Ren S, Zhou S, Zhang L, Su C, Zhang Z, et al. Predictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced NSCLC patients. Jap J Clin Oncol. 2010;40(10):954-60. doi: 10.1093/jjco/hyq071.
    • (2010) Jap J Clin Oncol , vol.40 , Issue.10 , pp. 954-960
    • Zhou, C.1    Ren, S.2    Zhou, S.3    Zhang, L.4    Su, C.5    Zhang, Z.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.